PYC Therapeutics Overview

  • Founded
  • 2001
  • Status
  • Public
  • Employees
  • 25
  • Stock Symbol
  • PYC
Stock Symbol
  • Share Price
  • $0.11
  • (As of Thursday Closing)

PYC Therapeutics General Information


PYC Therapeutics Ltd is an RNA therapeutics drug development company, leveraging a proprietary delivery platform to solve the major challenge in RNA therapeutics - safe and effective delivery of the drug inside the cell. Geographically, it operates only in Australia.

Contact Information

Formerly Known As
Phylogica, Ltd., Phylogica Limited, Phylogica
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Stock Exchange
Primary Office
  • The Esplanade Mount Pleasant
  • Suite 7, 8
  • Nedlands, Western Australia 6153
  • Australia
+61 (08) 0000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PYC Therapeutics Stock Performance

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.11 $0.11 $0.08 - $0.15 $349M 3.18B 572K

PYC Therapeutics Financials Summary

In Thousands,
TTM 30-Jun-2021 FY 2021 30-Jun-2021 FY 2020 30-Jun-2020 FY 2019 30-Jun-2019
EV 333,332 333,332 216,473 49,614
EBITDA (6,119) (4,985)
Net Income (4,570) (2,917)
Total Assets 21,676 4,693
Total Debt 548 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

PYC Therapeutics Valuation & Funding

Deal Type Date Amount Valuation/
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore PYC Therapeutics‘s full profile, request access.

Request a free trial

PYC Therapeutics Executive Team (6)

Name Title Board Seat Contact Info
Stewart James Washer Ph.D Chief Executive Officer & Executive Director
Rohan Hockings Chief Executive Officer
Glenn Noronha Ph.D Chief Development Officer
You’re viewing 3 of 6 executive team members. Get the full list »

PYC Therapeutics Board Members (4)

Name Representing Role Since
Bernard Hockings MD PYC Therapeutics Board Member 000 0000
You’re viewing 1 of 4 board members. Get the full list »

PYC Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial